We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App





Winners Announced of the 14th MEDICA Start-up Competition

By HospiMedica International staff writers
Posted on 20 Nov 2025

At the MEDICA 2025 edition of the MEDICA INNOVATION FORUM, the 14th MEDICA Start-up Competition announced this year’s winners, with SVAN Technologies GmbH taking both 1st place and the Public Vote, followed by AcroCyte Therapeutics in 2nd place and Virtuosis AI in 3rd place. More...

Below is a closer look at the technologies driving these standout young companies and the potential impact they bring to healthcare.

SVAN Technologies GmbH (Vienna, Austria) was awarded the first place prize with its deep-tech innovation for neonatal emergency vascular access. The company is developing an autonomous bone-drilling device designed to provide safe, fast, and precise intraosseous access in premature and full-term newborns. The device automatically detects bone-marrow entry, features a safety-stop mechanism, and offers precise wrist control to minimize injury during urgent, life-saving procedures. Because securing fast intraosseous access for medication and fluid delivery can be challenging in neonatal emergencies, this patented technology could greatly enhance outcomes for newborns and raise the standard of care globally.

AcroCyte Therapeutics (Taipei, Taiwan) secured second place with its precision-medicine and cell-therapy technology. Its core innovation, R³CE (Rapid, Reproducible, Rare Cell Expansion), enables the culture of three-dimensional tissues from a single cell and supports the creation of ex-vivo 3D models from rare cells, stem cells, or circulating tumor cells. This powerful platform for 3D cell culture can support breakthroughs in cancer research, clinical treatment development, and drug discovery.

Virtuosis AI (Lausanne, Switzerland) took third place with its AI-driven voice-analysis platform. By analyzing tone, pitch, cadence, and other acoustic features, the system can detect early indicators of stress, anxiety, and communication difficulties The platform integrates with Microsoft Teams to deliver confidential voice-analysis data and actionable results.

This year’s competition once again demonstrated MEDICA’s role as a global showcase for emerging healthcare technologies. Beyond the top three, the 15 selected finalists represented a broad spectrum of the global medtech innovation landscape, spanning categories such as AI in Healthcare, Health Apps, Lab Diagnostics, and Robotics. The MEDICA Start-up Competition continues to act as a catalyst for identifying promising young companies poised to shape the next generation of medical technology.

Related Links:
SVAN Technologies GmbH
AcroCyte Therapeutics
Virtuosis AI


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hypodermic Syringe
SurTract™ Safety Syringe
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Masimo smartSET pulse oximetry with PPG AFib and OIRD Detection (Photo courtesy of Masimo)

Smart Pulse Oximetry Supports Earlier Recognition of Arrhythmias and Respiratory Risk

On general care floors, respiratory compromise and arrhythmias can develop between routine checks. Atrial fibrillation often goes undiagnosed in older adults, while opioid-induced respiratory depression... Read more

Surgical Techniques

view channel
Image: 3D-printed nitinol tapered flow-diverter stent with variable fiber density, sectional size and shape. (Photo courtesy of IMDEA Materials Institute)

3D Printing Method Could Enable More Flexible Cardiovascular Implants

Minimally invasive transcatheter devices must compress into small catheters and recover their intended shape after deployment, creating a design challenge for cardiovascular implants with complex, patient-specific... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Medical Imaging

view channel
Image: Visual Abstract (Sinuo Gao, Zhaoqi Zhang, Chao Shi, Cheng Cheng, Xindi Ma, Xinming Zhao, Yunjiang Liu Journal of Nuclear Medicine Oct 2026, 67 (10) 1552-1559; DOI: 10.2967/jnumed.125.271529)

Targeted PET/CT Predicts Early Treatment Response in HER2-Positive Breast Cancer

HER2-positive breast cancer is an aggressive subtype that accounts for a substantial proportion of breast cancer cases. Patients often receive neoadjuvant therapy before surgery to shrink tumors, but assessing... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.